2 results
Approved WMOCompleted
To evaluate the safety and performance of the TriCinch System* in the treatment of functional tricuspid regurgitation
Approved WMOCompleted
To assess indacaterol (300 and 600 ug once daily via SDDPI) superiority in patients with COPD as compared to placebo with respect to 24 h post dose (through) FEV1 after 12 weeks of treatment.